I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Merikhian, Parnaz
11
results:
Search for persons
X
Format
Online (11)
Mediatypes
Articles (Online) (6)
OpenAccess-fulltext (5)
Sorted by: Relevance
Sorted by: Year
?
1
MUC1 is a potential target to overcome trastuzumab resistan..:
Hosseinzadeh, Aysooda
;
Merikhian, Parnaz
;
Naseri, Nazanin
..
Cancer Cell International. 22 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
2
Anti-cancer therapeutic strategies based on HGF/MET, EpCAM,..:
Barzaman, Khadijeh
;
Vafaei, Rana
;
Samadi, Mitra
...
Cancer Cell International. 22 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
3
Crosstalk between MUC1 and VEGF in angiogenesis and metasta..:
Khodabakhsh, Farnaz
;
Merikhian, Parnaz
;
Eisavand, Mohammad Reza
.
Cancer Cell International. 21 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1186/..
?
4
Recombinant nanobody against MUC1 tandem repeats inhibits g..:
Merikhian, Parnaz
;
Darvishi, Behrad
;
Jalili, Neda
...
Molecular Oncology. 16 (2021) 2 - p. 485-507 , 2021
Link:
https://doi.org/10.1002/..
?
5
Triple-negative breast cancer: understanding Wnt signaling ..:
Merikhian, Parnaz
;
Eisavand, Mohammad Reza
;
Farahmand, Leila
Cancer Cell International. 21 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1186/..
?
6
Monoclonal antibody-based therapeutics, targeting the epide..:
Moradi-Kalbolandi, Shima
;
Hosseinzade, Aysooda
;
Salehi, Malihe
..
Journal of Pharmacy and Pharmacology. 70 (2018) 7 - p. 841-854 , 2018
Link:
https://doi.org/10.1111/..
?
7
Recombinant nanobody against MUC1 tandem repeats inhibits g..:
Parnaz Merikhian
;
Behrad Darvishi
;
Neda Jalili
...
https://doi.org/10.1002/1878-0261.13123. , 2022
Link:
https://doi.org/10.1002/..
?
8
Anti-cancer therapeutic strategies based on HGF/MET, EpCAM,..:
Khadijeh Barzaman
;
Rana Vafaei
;
Mitra Samadi
...
https://doi.org/10.1186/s12935-022-02658-z. , 2022
Link:
https://doi.org/10.1186/..
?
9
MUC1 is a potential target to overcome trastuzumab resistan..:
Aysooda Hosseinzadeh
;
Parnaz Merikhian
;
Nazanin Naseri
..
https://doi.org/10.1186/s12935-022-02523-z. , 2022
Link:
https://doi.org/10.1186/..
?
10
Crosstalk between MUC1 and VEGF in angiogenesis and metasta..:
Farnaz Khodabakhsh
;
Parnaz Merikhian
;
Mohammad Reza Eisavand
.
https://doi.org/10.1186/s12935-021-01899-8. , 2021
Link:
https://doi.org/10.1186/..
?
11
Triple-negative breast cancer: understanding Wnt signaling ..:
Parnaz Merikhian
;
Mohammad Reza Eisavand
;
Leila Farahmand
https://doi.org/10.1186/s12935-021-02107-3. , 2021
Link:
https://doi.org/10.1186/..
1-11